Study Information

Title: A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Patients With Moderate to Severe Ulcerative Colitis in Patients Naive to TNF Inhibitors (Study #1) External
Status: Recruiting participants
Conditions: Ulcerative Colitis
Interventions: Drug: adalimumab; Other: adalimumab placebo; Drug: etrolizumab; Other: etrolizumab placebo
Health Topics: Ulcerative Colitis

Contact Information